A detailed history of Advisors Asset Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 4,983 shares of UTHR stock, worth $1.79 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,983
Previous 5,132 2.9%
Holding current value
$1.79 Million
Previous $1.18 Million 34.72%
% of portfolio
0.03%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $34,010 - $47,536
-149 Reduced 2.9%
4,983 $1.59 Million
Q1 2024

May 14, 2024

SELL
$210.76 - $249.51 $383,372 - $453,858
-1,819 Reduced 26.17%
5,132 $1.18 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $161,804 - $193,475
-753 Reduced 9.77%
6,951 $1.53 Million
Q2 2023

Aug 14, 2023

SELL
$205.19 - $232.99 $23,802 - $27,026
-116 Reduced 1.48%
7,704 $1.7 Million
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $312,669 - $405,417
1,468 Added 23.11%
7,820 $1.75 Million
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $948,399 - $1.29 Million
4,605 Added 263.59%
6,352 $1.77 Million
Q3 2022

Nov 08, 2022

SELL
$203.3 - $244.17 $46,352 - $55,670
-228 Reduced 11.54%
1,747 $366,000
Q2 2022

Aug 08, 2022

SELL
$174.81 - $241.14 $211,869 - $292,261
-1,212 Reduced 38.03%
1,975 $465,000
Q1 2022

May 17, 2022

SELL
$166.16 - $213.96 $3,655 - $4,707
-22 Reduced 0.69%
3,187 $572,000
Q4 2021

Feb 15, 2022

BUY
$184.32 - $216.08 $69,120 - $81,030
375 Added 13.23%
3,209 $693,000
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $65,109 - $77,786
362 Added 14.64%
2,834 $523,000
Q2 2021

Jul 30, 2021

BUY
$170.47 - $211.93 $131,943 - $164,033
774 Added 45.58%
2,472 $444,000
Q1 2021

May 07, 2021

SELL
$153.94 - $174.85 $6,619 - $7,518
-43 Reduced 2.47%
1,698 $284,000
Q4 2020

Feb 12, 2021

BUY
$101.87 - $151.79 $13,039 - $19,429
128 Added 7.94%
1,741 $264,000
Q3 2020

Nov 16, 2020

BUY
$99.9 - $121.13 $74,625 - $90,484
747 Added 86.26%
1,613 $163,000
Q2 2020

Aug 12, 2020

BUY
$92.74 - $125.82 $79,756 - $108,205
860 Added 14333.33%
866 $105,000
Q1 2019

May 15, 2019

SELL
$107.15 - $126.84 $63,754 - $75,469
-595 Reduced 99.0%
6 $1,000
Q4 2018

Jan 31, 2019

SELL
$101.4 - $128.73 $10,444 - $13,259
-103 Reduced 14.63%
601 $65,000
Q3 2018

Nov 15, 2018

SELL
$113.81 - $129.46 $172,080 - $195,743
-1,512 Reduced 68.23%
704 $90,000
Q2 2018

Aug 15, 2018

SELL
$101.14 - $118.31 $26,397 - $30,878
-261 Reduced 10.54%
2,216 $251,000
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $12,543 - $17,776
-117 Reduced 4.51%
2,477 $287,000
Q4 2017

Feb 13, 2018

SELL
$118.58 - $151.28 $12,213 - $15,581
-103 Reduced 3.82%
2,594 $384,000
Q3 2017

Nov 07, 2017

BUY
$114.6 - $136.81 $309,076 - $368,976
2,697
2,697 $316,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.